121 related articles for article (PubMed ID: 16303682)
1. Therapeutic management of laryngeal cancer. Results of a study of 356 patients from the Cancer Registry of the Somme, France.
Ayache S; Peng J; Chatelain D; De La Roche Saint-Andre G; Mineur O; Raverdy N; Dubreuil A; Krzisch C; Strunski V
Acta Otolaryngol; 2005 Dec; 125(12):1323-6. PubMed ID: 16303682
[TBL] [Abstract][Full Text] [Related]
2. Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation.
Herchenhorn D; Dias FL; Ferreira CG; Araújo CM; Lima RA; Small IA; Kligerman J
ORL J Otorhinolaryngol Relat Spec; 2008; 70(6):381-8. PubMed ID: 18984974
[TBL] [Abstract][Full Text] [Related]
3. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?
Wang J; Kulaylat M; Rockette H; Hassett J; Rajput A; Dunn KB; Dayton M
Ann Surg; 2009 Apr; 249(4):559-63. PubMed ID: 19300237
[TBL] [Abstract][Full Text] [Related]
4. The effect of treatment on survival in patients with advanced laryngeal carcinoma.
Gourin CG; Conger BT; Sheils WC; Bilodeau PA; Coleman TA; Porubsky ES
Laryngoscope; 2009 Jul; 119(7):1312-7. PubMed ID: 19444887
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity measurement in patients with laryngeal squamous cell carcinoma.
Castro MA; Dedivitis RA; Ribeiro KC
ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):146-52. PubMed ID: 17264530
[TBL] [Abstract][Full Text] [Related]
7. [Larynx cancer in France: descriptive epidemiology and incidence estimation].
Peng J; Ménégoz F; Lesec'h JM; Remontet L; Grosclaude P; Buémi A; Guizard AV; Tretarre B; Danzon A; Velten M; Maarouf N; Jougla E; Launoy G; Dubreuil A
Bull Cancer; 2004 Apr; 91(4):363-8. PubMed ID: 15242320
[TBL] [Abstract][Full Text] [Related]
8. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
9. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic factors in supraglottic laryngeal cancer: a review of 74 cases].
Zapater E; Campos A; Fortea M; Armengot M; Basterra J
Acta Otorrinolaringol Esp; 2000 Mar; 51(2):120-8. PubMed ID: 10804113
[TBL] [Abstract][Full Text] [Related]
11. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
McCaffrey JC
Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
[TBL] [Abstract][Full Text] [Related]
12. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
Yung KC; Piccirillo JF
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
[TBL] [Abstract][Full Text] [Related]
13. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
[TBL] [Abstract][Full Text] [Related]
14. Soft-tissue sarcomas of the head and neck: a retrospective analysis of the Alberta experience 1974 to 1999.
Huber GF; Matthews TW; Dort JC
Laryngoscope; 2006 May; 116(5):780-5. PubMed ID: 16652087
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years.
Tamura Y; Tanaka S; Asato R; Hirano S; Yamashita M; Tamaki H; Ito J
Acta Otolaryngol Suppl; 2007 Feb; (557):62-5. PubMed ID: 17453448
[TBL] [Abstract][Full Text] [Related]
16. Five-year survival rates and time trends of laryngeal cancer in the US population.
Cosetti M; Yu GP; Schantz SP
Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):370-9. PubMed ID: 18427002
[TBL] [Abstract][Full Text] [Related]
17. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
[TBL] [Abstract][Full Text] [Related]
18. Resected synchronous primary malignant lung tumors: a population-based study.
Rostad H; Strand TE; Naalsund A; Norstein J
Ann Thorac Surg; 2008 Jan; 85(1):204-9. PubMed ID: 18154811
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors identified by Cox multivariate analysis of surgically treated 1018 laryngeal cancer patients].
Du Q; Ji WY; Guan C; Xu QY
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):211-3. PubMed ID: 16875608
[TBL] [Abstract][Full Text] [Related]
20. No improvement in the overall survival of 194 patients with chondrosarcoma in Finland in 1971-1990.
Söderström M; Ekfors TO; Böhling TO; Teppo LH; Vuorio EI; Aro HT
Acta Orthop Scand; 2003 Jun; 74(3):344-50. PubMed ID: 12899557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
